Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Raiola

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2020
Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and InfectionElisa Furfaro, Laura Nicolini, Andrea Della Vecchia, et al.
Journal of Hematology & Oncology|February 14, 2023
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMTFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.
Blood|October 24, 2002
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantationAlida Dominietto, Teresa Lamparelli, Anna Maria Raiola, et al.
Blood Advances|April 10, 2024
Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMTArnon Nagler, Myriam Labopin, Johanna Tischer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 28, 2014
CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantationAlessandra Stasia, Anna Ghiso, Federica Galaverna, et al.
Frontiers in Immunology|March 14, 2022
CD19-Targeted Immunotherapies for Diffuse Large B-Cell LymphomaMassimiliano Gambella, Simona Carlomagno, Anna Maria Raiola, et al.
Bone Marrow Transplantation|December 11, 2024
Pre-engraftment bloodstream infection after allogeneic haematopoietic cell transplant: 18-year trends in aetiology, resistance and mortalityAnna Falcó-Roget, Anna Maria Raiola, Elisa Balletto, et al.
European Journal of Immunology|May 16, 2025
The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES<sup>+</sup> Tr1-Like CellsNadia Pulvirenti, Chiara Vasco, Camilla Righetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2012
Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioningAnna Maria Raiola, Alida Dominietto, Anna Ghiso, et al.
American Journal of Hematology|June 13, 2022
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of ageFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2020
Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and InfectionElisa Furfaro, Laura Nicolini, Andrea Della Vecchia, et al.
Journal of Hematology & Oncology|February 14, 2023
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMTFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.
Blood|October 24, 2002
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantationAlida Dominietto, Teresa Lamparelli, Anna Maria Raiola, et al.
Blood Advances|April 10, 2024
Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMTArnon Nagler, Myriam Labopin, Johanna Tischer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 28, 2014
CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantationAlessandra Stasia, Anna Ghiso, Federica Galaverna, et al.
Frontiers in Immunology|March 14, 2022
CD19-Targeted Immunotherapies for Diffuse Large B-Cell LymphomaMassimiliano Gambella, Simona Carlomagno, Anna Maria Raiola, et al.
Bone Marrow Transplantation|December 11, 2024
Pre-engraftment bloodstream infection after allogeneic haematopoietic cell transplant: 18-year trends in aetiology, resistance and mortalityAnna Falcó-Roget, Anna Maria Raiola, Elisa Balletto, et al.
European Journal of Immunology|May 16, 2025
The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES<sup>+</sup> Tr1-Like CellsNadia Pulvirenti, Chiara Vasco, Camilla Righetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2012
Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioningAnna Maria Raiola, Alida Dominietto, Anna Ghiso, et al.
American Journal of Hematology|June 13, 2022
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of ageFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.
Pageof 9